NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers. … [Read more…]
High and Predictable Growth Full Year 2022 Guidance Reaffirmed Robust EPS Expansion NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2022 (first quarter 2022). Financial results are … [Read more…]
Recent Filing Only Intended as a Distraction to Shareholders and has No Impact on Blue Ocean Campaign to STOP the Cellenkos Transaction NEW YORK–(BUSINESS WIRE)–Blue Ocean Structure Investment Company Ltd. (“Blue Ocean”), a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today commented on what Blue Ocean believes to … [Read more…]
Judge rules in MedMen’s favor on all counts, opens the door for MedMen to recover attorneys’ fees Separately, the Company announces departure of its chief strategy officer LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced the Company has … [Read more…]
–MEI Begins Fourth Fiscal Quarter with $169.0 Million in Cash– SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the quarter ended March 31, 2022, and highlighted recent corporate events. “The third fiscal quarter of 2022 was underscored by a meeting with … [Read more…]
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational New Drug application (IND) of BPI-442096 , a small molecule Src homology region 2 domain-containing phosphatase 2 (SHP2) inhibitor, in solid tumors. Xcovery will initiate a phase I clinical … [Read more…]
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022, at 7.00am ET. It was also announced that Dr. Steve Cutler, CEO of ICON plc, will present at … [Read more…]
MSP Recovery, Inc. to Trade on Nasdaq Under the Symbol “MSPR” Starting May 24 CORAL GABLES, Fla.–(BUSINESS WIRE)–MSP Recovery, Inc. (“MSPR”), formerly known as Lionheart Acquisition Corporation II, a Delaware corporation (Nasdaq: LCAPU, LCAP, LCAPW, “Lionheart” or “LCAP”), today announced that it has closed the previously announced business combination (the “transaction”) with MSP Recovery, LLC. … [Read more…]
SonarMD’s platform pinpoints patients in need of mental health support better than claims data alone CHICAGO–(BUSINESS WIRE)–#IBD—SonarMD, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using … [Read more…]
The endurance cyclist will attempt a 700 mile non-stop traverse, climbing 63,000ft through Southern California in aid of charity NORFOLK, Va.–(BUSINESS WIRE)–UHSM Health Share, a faith-based health care nonprofit founded on Christian beliefs and values, today announced its ambassador athlete Grant Lottering, extreme endurance cyclist, international motivational speaker and Laureus Sport for Good Ambassador, will … [Read more…]
